← All trials
NCT04768764
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 16, 2021
- Primary completion
- Oct 16, 2021
- Completion date
- Apr 16, 2022
- First posted
- Feb 24, 2021
- Last posted
- Feb 24, 2021
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Izmir Bozyaka Training and Research HospitalLead sponsor
- Izmir Bozyaka Training and Research HospitalReponsible party - principal investigator
- Izmir Bozyaka Training and Research HospitalStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.